News
Yap Boum, PhD, MPH, deputy incident manager for Africa CDC's mpox response, said Mozambique's three cases involve two men and ...
European Medicines Agency Supports Streamlined Development Pathway for GEO-MVA Vaccine Candidate via a Single Phase 3 ...
The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...
Officials at the Africa Centre for Disease Control and Prevention (Africa CDC) have reported an increase in high-risk events, ...
Cholera and mpox outbreaks have killed 4,200 people in different parts of Africa, the Africa Centers for Disease Control and ...
Though cases are falling in two of the region's high-burden countries, officials from the Africa Centres for Disease Control ...
Women receive dignity kits at Medical Teams International distribution event in Ethiopia.
In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.
Continuing to vaccinate for mpox through a routine targeted program for gay and bisexual men delivered by sexual health services will greatly reduce the number of cases and save the NHS millions ...
Thirdly, there is a strong financial case for choosing MPox as the indication. This business case has become even stronger with the failure of tecovirimat (Tpoxx) in clinical trial against MPox.
Although mpox has been detected in paediatric populations in central and west Africa for decades, evidence synthesis on paediatric, maternal, and congenital mpox, and the use of vaccines and ...
There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results